Therapeutic strategies for catatonia in paraneoplastic encephalitis

World Journal of Biological Psychiatry

Volumn 9, Issue 3, 2008, Pages 236-240

  Kaestner, Florian ^a   Mostert, Christian ^a   Behnken, Andreas ^a   Boeckermann, Iris ^a   Ternes, Florian ^a   Diedrich, Markus ^a   Zavorotnyy, Maxim ^a   Arolt, Volker ^a   Weckesser, Matthias ^a   Rothermundt, Matthias ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Catalepsy; Catatonia; Electroconvulsive therapy; Paraneoplastic encephalitis

Indexed keywords

ACICLOVIR; AMISULPRIDE; AMPICILLIN; CEFTRIAXONE; CLOZAPINE; CORTISONE; DIAZEPAM; DULOXETINE; ESCITALOPRAM; FLUORODEOXYGLUCOSE; HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADD ON THERAPY; ADULT; ANTEROGRADE AMNESIA; ARTICLE; AUTONOMIC DYSFUNCTION; BRAIN METABOLISM; CANCER SURGERY; CASE REPORT; CATALEPSY; CATATONIA; DISEASE COURSE; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; ELECTROCONVULSIVE THERAPY; ENCEPHALITIS; FRONTAL CORTEX; HUMAN; MALE; MENTAL DISEASE; MUTISM; NEUROLOGIC DISEASE; PARANEOPLASTIC NEUROPATHY; PLASMAPHERESIS; SEIZURE; SEMINOMA; STUPOR; TEMPORAL LOBE; TESTIS TUMOR; TUMOR RECURRENCE;

ADULT; CATATONIA; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PLASMAPHERESIS; TESTICULAR NEOPLASMS;

EID: 48249100796     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970701459802     Document Type: Article

References (21)

1. Ances, BM, Vitaliani, R. Taylor, RA et al. (2005) Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. 128, pp. 1764-1777.
2. Benke, T., Wagner, M. Pallua, AK et al. (2004) Long-term cognitive and MRI findings in a patient with paraneoplastic limbic encephalitis. 66, pp. 217-224.
3. Braunig, P. and Kruger, S. (2005) Katatonie Eine Ubersicht. 32, p. S7.
4. Braunig, P., Kruger, S. Shugar, G. et al. (2000) The Catatonia Rating Scale I-Development, reliability, and use. 41, pp. 147-158.
5. Dropcho, EJ (2005) Update on paraneoplastic syndromes. 18, pp. 331-336.
6. Folkerts, HW, Stadtland, C. and Reker, T. (1998) ECT for organic catatonia due to hereditary Cerebellar Ataxia. 14, pp. 53-55.
7. Gultekin, SH, Rosenfeld, MR Voltz, R. et al. (2000) Paraneoplastic limbic encephalitis: Neurological symptoms, immunological findings and tumour association in 50 patients. 123, pp. 1481-1494.
8. Lawn, ND, Westmoreland, BF Kiely, MJ et al. (2003) Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. 78, pp. 1363-1368.
9. Malur, C., Pasol, E. and Francis, A. (2001) ECT for prolonged catatonia. 17, pp. 55-59.
10. Rohland, BM, Carroll, BT and Jacoby, RG (1993) ECT in the treatment of the catatonic syndrome. 29, pp. 255-261.
11. Northoff, G. (2002) Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology. 109, pp. 1453-1467.
12. Northoff, G., Koch, A. Wenke, J. et al. (1999) Catatonia as a Psychomotor syndrome: A rating scale and extrapyramidal motor symptoms. 14, pp. 404-416.
13. Onishi, H., Onose, M. Yamada, T. et al. (2003) Brief psychotic disorder associated with bereavement in a patient with terminal-stage uterine cervical cancer: A case report and review of the literature. 11, pp. 491-493.
14. Pfister Ch, Vidart, A. Lop-Vip, S. et al. (2003) Assessment of paraneoplastic limbic encephalitis in testicular cancer. 15, p. 219.
15. Spear, J., Ranger, M. and Herzberg, J. (1997) The treatment of stupor associated with MRI evidence of cerebrovascular disease. 12, pp. 791-794.
16. Tandon, R., Walden, M. and Spencer, F. (1988) Catatonia as a manifestation of paraneoplastic encephalopathy. 49, pp. 121-122.
17. Taylor, MA and Fink, M. (2003) Catatonia in psychiatric classification: A home of its own. 160, pp. 1233-1241.
18. Van den Eede, F, Van Hecke, J. Van Dalfsen, A. et al. (2005) The use of atypical antipsychotics in the treatment of catatonia. 20, pp. 422-429.
19. Voltz, R. (2002) Paraneoplastic neurological syndromes: An update on diagnosis, pathogenesis and therapy. 1, pp. 294-305.
20. Zwil, AS and Pelchat, RJ (1994) ECT in the treatment of patients with neurological and somatic disease. 24, pp. 1-29.
21. Zwil, AS, McAllister, TW and Price, TR (1992) Safety and efficacy of ECT in depressed patients with organic brain disease: Review of a clinical experience. 8, pp. 103-109.